Evidence that APOE4 carrier status differentially affects both central and peripheral metabolism suggests that the underlying pathogenesis of AD varies by genotype and that whole-body metabolism may be more important to AD pathogenesis in APOE4 carriers. The gene discussed is APOE; the disease is Alzheimer disease.